Clair raises $11.6m for continuous hormone tracking

Non-invasive continuous hormone monitoring arrives – and may find female physiology more complex than the textbooks suggest. Clair Health has closed a new seed round, bringing its total funding to $11.6 million. The round was led by Khosla Ventures, with participation from a16z speedrun and a clutch of other investors, and the capital is set […] The post Clair raises $11.6m for continuous hormone tracking appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.

Read full coverage at Longevity.Technology →

Clair raises $11.6m for continuous hormone tracking

More from Longevity

Mediterranean diet may activate tiny proteins that protect the heart and brain

Calico and Revel scientists reverse age-related protein damage

As life expectancy rises, talks start on a UN treaty to protect older persons

Elysium Health links NAD+ to menopause in new study

"Muscle is worth its weight in gold:" Life Time Experts Share Their Top Strength Training Tips for Women

SkinStylus secures new FDA win for healthier skin aging